Morgan Stanley Lowers DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $23.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by equities researchers at Morgan Stanley from $30.00 to $23.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. Morgan Stanley’s target price suggests a potential upside of 23.13% from the company’s previous close.

Several other research firms also recently weighed in on XRAY. Mizuho assumed coverage on DENTSPLY SIRONA in a report on Wednesday, December 4th. They issued a “neutral” rating and a $21.00 price objective for the company. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research note on Thursday, November 7th. Barrington Research dropped their price objective on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. StockNews.com downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Leerink Partnrs cut DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $27.91.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $18.68 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60. The firm has a market capitalization of $3.71 billion, a P/E ratio of -9.02, a P/E/G ratio of 1.93 and a beta of 0.96. The company’s fifty day moving average price is $21.07 and its 200 day moving average price is $24.04.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The business had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business’s revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.49 earnings per share. As a group, sell-side analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently added to or reduced their stakes in XRAY. UMB Bank n.a. boosted its position in DENTSPLY SIRONA by 430.3% during the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 753 shares in the last quarter. Capital Performance Advisors LLP acquired a new stake in DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. LRI Investments LLC increased its holdings in DENTSPLY SIRONA by 82.7% during the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares in the last quarter. Rothschild Investment LLC acquired a new position in DENTSPLY SIRONA during the second quarter worth about $32,000. Finally, Kennebec Savings Bank acquired a new position in DENTSPLY SIRONA during the third quarter worth about $35,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.